Figure legends
Figure 1: Mapping from source database to target database generated by
OHDSI’s Rabbit-In-a-Hat tool
Figure 2: Example of mapping from local concepts to concepts in the OMOP
vocabulary
Figure 3: Study overview detailing criteria for inclusion and exclusion,
exposure and outcomes
Figure 4: Flow diagram showing number of persons in final qualifying
cohort
Figure 5. 100%, horizontally-stacked, utilization-adjusted bar charts
of efficacy and safety. The vertical height of each bar is proportional
to the number of patients in the cohort for 4 years of follow up. The
number of patients experiencing the events of interest are represented
as proportions within each bar. Event proportions are unadjusted for
confounding factors.
Drug A: Apixaban, Drug B: Rivaroxaban, Drug C: Warfarin
Figure 6: Landmark analysis at six months; 100%, horizontally-stacked,
utilization-adjusted bar charts of efficacy and safety limited to a
follow-up period of six months. The vertical height of each bar is
proportional to the number of patients in the cohort for 4 years of
follow up. The number of patients experiencing the events of interest
are represented as proportions within each bar. Event proportions are
unadjusted for confounding factors.
Drug A: Apixaban, Drug B: Rivaroxaban, Drug C: Warfarin